We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Blend Labs
BLND
$386M
| $289K | ﹤0.01% |
290,119
+13,162
| +5% | +$20.2K |
|
2627
Stoke Therapeutics
STOK
$2.11B
| $288K | ﹤0.01% |
34,597
+406
| +1% | +$3.66K |
|
2628
Sight Sciences
SGHT
$412M
| $287K | ﹤0.01% |
32,853
+845
| +3% | +$9.38K |
|
2629
Chewy
CHWY
$9.63B
| $286K | ﹤0.01% |
7,646
-170
| -2% | -$7.04K |
|
|
FIRY
2630
Firy Inc
FIRY
$163M
| $286K | ﹤0.01% |
24,110
+487
| +2% | +$6.46K |
|
2631
Nuvation Bio
NUVB
$2.32B
| $285K | ﹤0.01% |
171,731
-2,598
| -1% | -$5.27K |
|
|
SRTA
2632
Strata Critical Medical Inc
SRTA
$512M
| $284K | ﹤0.01% |
84,042
+587
| +0.7% | +$2.39K |
|
2633
Tango Therapeutics
TNGX
$4.41B
| $283K | ﹤0.01% |
71,721
+1,031
| +1% | +$5.98K |
|
2634
BCB Bancorp
BCBP
$161M
| $282K | ﹤0.01% |
21,454
+226
| +1% | +$3.75K |
|
2635
Xeris Biopharma Holdings
XERS
$1.45B
| $282K | ﹤0.01% |
172,851
+6,990
| +4% | +$8.75K |
|
|
CMBM
2636
DELISTED
Cambium Networks
CMBM
| $279K | ﹤0.01% |
15,760
+599
| +4% | +$12.2K |
|
2637
Century Casinos
CNTY
$34M
| $279K | ﹤0.01% |
38,052
+735
| +2% | +$6.14K |
|
2638
Colony Bankcorp
CBAN
$467M
| $278K | ﹤0.01% |
27,293
-49
| -0.2% | -$595 |
|
2639
908 Devices
MASS
$364M
| $278K | ﹤0.01% |
32,340
+404
| +1% | +$3.6K |
|
2640
Lands' End
LE
$403M
| $277K | ﹤0.01% |
28,511
+2,473
| +9% | +$20.7K |
|
2641
PMV Pharmaceuticals
PMVP
$63.5M
| $277K | ﹤0.01% |
57,998
+1,584
| +3% | +$11.1K |
|
2642
Aura Biosciences
AURA
$826M
| $276K | ﹤0.01% |
29,787
+7,117
| +31% | +$73.9K |
|
2643
Adicet Bio
ACET
$74.7M
| $274K | ﹤0.01% |
2,976
+140
| +5% | +$17.6K |
|
2644
MeiraGTx Holdings
MGTX
$1.21B
| $274K | ﹤0.01% |
52,927
+5,890
| +13% | +$40.8K |
|
2645
Rimini Street
RMNI
$471M
| $271K | ﹤0.01% |
65,858
+3,117
| +5% | +$14K |
|
|
BHIL
2646
DELISTED
Benson Hill, Inc.
BHIL
| $271K | ﹤0.01% |
6,741
+99
| +1% | +$7.39K |
|
2647
Blue Ridge Bankshares
BRBS
$332M
| $270K | ﹤0.01% |
26,506
-10
| -0% | -$119 |
|
2648
Parke Bancorp
PKBK
$405M
| $270K | ﹤0.01% |
15,163
-178
| -1% | -$3.54K |
|
2649
Tilly's
TLYS
$128M
| $270K | ﹤0.01% |
34,976
-296
| -0.8% | -$2.47K |
|
2650
Willdan Group
WLDN
$1.3B
| $270K | ﹤0.01% |
17,315
+206
| +1% | +$3.69K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.